Aurora Cannabis Stock Today

ACB Stock  USD 4.32  0.07  1.59%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Aurora Cannabis is trading at 4.32 as of the 19th of March 2025, a 1.59 percent decrease since the beginning of the trading day. The stock's open price was 4.39. Aurora Cannabis has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
11th of July 2014
Category
Healthcare
Classification
Health Care
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. The company has 54.88 M outstanding shares of which 4.7 M shares are presently shorted by investors with about 3.77 days to cover. More on Aurora Cannabis

Moving together with Aurora Stock

  0.85EQ EquilliumPairCorr
  0.72VALN Valneva SE ADRPairCorr

Moving against Aurora Stock

  0.59SABSW SAB BiotherapeuticsPairCorr
  0.49DRTS Alpha Tau MedicalPairCorr
  0.42ME 23Andme HoldingPairCorr
  0.42DSGN Design TherapeuticsPairCorr
  0.41VRDN Viridian Therapeutics Downward RallyPairCorr
  0.4DRRX Durect Earnings Call This WeekPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Aurora Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOMiguel Martin
Thematic IdeaCannabis (View all Themes)
Old Names[ALPHA BANK , ALPHA BANK , ALPHA BANK , ACB, ALPHA BANK , A-Cap Energy Ltd]
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, VN 30, VN Index, VN100, VN All Shares, Cannabis, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.30.29
Sufficiently Up
Slightly volatile
Total Current Liabilities88.8 M143.3 M
Way Down
Slightly volatile
Non Current Liabilities Total122.6 M129 M
Notably Down
Slightly volatile
Total Assets978.8 M964.5 M
Fairly Up
Slightly volatile
Total Current Assets515.1 M490.6 M
Sufficiently Up
Slightly volatile
Debt Levels
Aurora Cannabis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aurora Cannabis' financial leverage. It provides some insight into what part of Aurora Cannabis' total assets is financed by creditors.
Liquidity
Aurora Cannabis has 104.79 M in debt with debt to equity (D/E) ratio of 0.41, which is OK given its current industry classification. Aurora Cannabis has a current ratio of 5.03, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Aurora to invest in growth at high rates of return.

Change In Cash

(103.89 Million)
Aurora Cannabis (ACB) is traded on NASDAQ Exchange in USA. It is located in 90B Street SW, Edmonton, AB, Canada, T6X 1V8 and employs 1,073 people. Aurora Cannabis is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 259.17 M. Aurora Cannabis runs under Pharmaceuticals sector within Health Care industry. The entity has 54.88 M outstanding shares of which 4.7 M shares are presently shorted by investors with about 3.77 days to cover. Aurora Cannabis has about 439.14 M in cash with (68.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Check Aurora Cannabis Probability Of Bankruptcy
Ownership Allocation
Aurora Cannabis holds a total of 54.88 Million outstanding shares. Almost 86.94 percent of Aurora Cannabis outstanding shares are held by general public with 13.06 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aurora Ownership Details

Aurora Stock Institutional Holders

InstituionRecorded OnShares
Two Sigma Advisers, Llc2024-12-31
62.1 K
Td Asset Management Inc2024-12-31
58.6 K
Cubist Systematic Strategies, Llc2024-12-31
52 K
Mackenzie Investments2024-12-31
51 K
Group One Trading, Lp2024-12-31
41.4 K
Bulltick Wealth Management Llc2024-12-31
35.4 K
Sontag Advisory Llc2024-12-31
35 K
Geode Capital Management, Llc2024-12-31
32.5 K
Centiva Capital Lp2024-12-31
31.7 K
Tidal Investments Llc.2024-12-31
1.3 M
Goldman Sachs Group Inc2024-12-31
714.8 K
View Aurora Cannabis Diagnostics

Aurora Cannabis Historical Income Statement

At present, Aurora Cannabis' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's EBITDA is expected to grow to about 19.3 M, whereas Other Operating Expenses is forecasted to decline to about 195.6 M. View More Fundamentals

Aurora Stock Against Markets

Aurora Cannabis Corporate Directors

Adam SzwerasIndependent DirectorProfile
Margaret AtkinsIndependent DirectorProfile
Norma BeauchampIndependent DirectorProfile
Jason DyckIndependent DirectorProfile

Already Invested in Aurora Cannabis?

The danger of trading Aurora Cannabis is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aurora Cannabis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aurora Cannabis. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aurora Cannabis is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurora Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.92)
Earnings Share
(0.46)
Revenue Per Share
0.033
Quarterly Revenue Growth
0.285
Return On Assets
(0.01)
The market value of Aurora Cannabis is measured differently than its book value, which is the value of Aurora that is recorded on the company's balance sheet. Investors also form their own opinion of Aurora Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Aurora Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurora Cannabis' market value can be influenced by many factors that don't directly affect Aurora Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.